The effect of sulforaphane on markers of inflammation and metabolism in virally suppressed HIV patients

There are currently 1.2 million people living with HIV (Human Immunodeficiency Virus) in the United States. Virally suppressed HIV patients commonly experience chronic inflammation which increases the risk for other chronic conditions. This inflammation can be quantified with a variety of biomarkers...

Full description

Bibliographic Details

Published in:	Frontiers in Nutrition
Main Authors:	Jose Giron, Lauren Smiarowski, Johannah Katz
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-10-01
Subjects:	human immunodeficiency virus sulforaphane (cruciferous antioxidants) antioxidant — phytochemical studies metabolic syndome acquired immunodeficiency syndrome highly active antiretroviral therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2024.1357906/full